b2815 Tissue Engineering and Nanotheranostics “9.61x6.69”254 Tissue Engineering and Nanotheranostics
they are used in real patients. Reducing the dosage of nanocarriers
and enhancing their biodegradability in vivo are the most promising
solutions.
References
- Ferrari M. Cancer nanotechnology: Opportunities and challenges,
Nature reviews. Cancer 5 , 161–171 (2005). - Ma X, Lin C, Zhen W. Cancer care in China: A general review. Biomed.
Imaging Int. J. 4 , e39 (2008). - Xu GW. Gastric cancer in China: A review. J. R. Soc. Med. 74 , 210–211
(1981). - Yu KD, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM.
Development and trends of surgical modalities for breast cancer in
China: A review of 16year data. Ann. Surgi. Oncol. 14 , 2502–2509
(2007). - Chen W, Zheng R, Zeng H, Zhang S. Epidemiology of lung cancer in
China. Thoracic Cancer 6 , 209–215 (2015). - Zhou C. Lung cancer molecular epidemiology in China: Recent trends.
Transl. Lung Cancer. Res. 3 , 270–279 (2014). - Gao H. Chinese government admits existence of cancer villages.
Lancet. Oncol. 14 , 284 (2013). - Wen C. Chinese government urged to tame cancer threat. Lancet
Oncol. 6 , 453–455 (2005). - Moore MA, Kunimoto T, Park CB, Takasuka N, Tsuda H. Cross
country comparisons of colon and rectal cancer mortality suggest the
existence of differences in risk factors in eastern and western Europe.
Eur. J. Cancer Prevention (ECP). 8 , 67–71 (1999). - Cole P, Rodu B. Declining cancer mortality in the United States.
Cancer 78 , 2045–2048 (1996). - Tao JJ, Visvanathan K, Wolff AC. Long term side effects of adjuvant
chemotherapy in patients with early breast cancer. Breast 24 (2),
S149–S153 (2015). - Wujcik D. Current research in side effects of highdose chemotherapy.
Sem. Oncol. Nur. 8 , 102–112 (1992). - Herrera FG, Cruz OS, Achtari C, Bourhis J, Ozsahin M. Longterm
outcome and late side effects in endometrial cancer patients treated
with surgery and postoperative radiation therapy. Ann. Surg. Oncol.
21 , 2390–2397 (2014).